AgenciesRelated
European stocks extended their recovery on Tuesday after a full US approval of a COVID-19 vaccine boosted Wall Street to record highs, while latest data showed a stronger-than-expected economic recovery in Germany.
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
Travel and leisure, technology and mining stocks were the top gainers, up between 0.9% and 1.2%.
Wall Street's Nasdaq reached an all-time closing high after US health regulators granted full approval to the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE in a move that could accelerate US inoculations.
Meanwhile, data showed Germany's gross domestic product grew by 1.6% on the quarter from April to June, slightly up from its previous estimate of 1.5% as private consumption and state spending helped.
Marks and Spencer Group rose 3.1% to the top of the STOXX 600 after Berenberg and Credit Suisse raised their price targets on the company's stock.
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
Travel and leisure, technology and mining stocks were the top gainers, up between 0.9% and 1.2%.
Wall Street's Nasdaq reached an all-time closing high after US health regulators granted full approval to the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE in a move that could accelerate US inoculations.
Meanwhile, data showed Germany's gross domestic product grew by 1.6% on the quarter from April to June, slightly up from its previous estimate of 1.5% as private consumption and state spending helped.
Marks and Spencer Group rose 3.1% to the top of the STOXX 600 after Berenberg and Credit Suisse raised their price targets on the company's stock.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
